173 related articles for article (PubMed ID: 27260311)
21. von Willebrand Factor-Rich Platelet Thrombi in the Liver Cause Sinusoidal Obstruction Syndrome following Oxaliplatin-Based Chemotherapy.
Nishigori N; Matsumoto M; Koyama F; Hayakawa M; Hatakeyayama K; Ko S; Fujimura Y; Nakajima Y
PLoS One; 2015; 10(11):e0143136. PubMed ID: 26580395
[TBL] [Abstract][Full Text] [Related]
22. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis.
Rubbia-Brandt L; Lauwers GY; Wang H; Majno PE; Tanabe K; Zhu AX; Brezault C; Soubrane O; Abdalla EK; Vauthey JN; Mentha G; Terris B
Histopathology; 2010 Mar; 56(4):430-9. PubMed ID: 20459550
[TBL] [Abstract][Full Text] [Related]
23. Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases.
Rubbia-Brandt L; Mentha G; Terris B
J Am Coll Surg; 2006 Jan; 202(1):199-200. PubMed ID: 16377516
[No Abstract] [Full Text] [Related]
24. Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab.
Hubert C; Sempoux C; Humblet Y; van den Eynde M; Zech F; Leclercq I; Gigot JF
HPB (Oxford); 2013 Nov; 15(11):858-64. PubMed ID: 23458554
[TBL] [Abstract][Full Text] [Related]
25. Kinetic Changes in Liver Parenchyma After Preoperative Chemotherapy for Patients with Colorectal Liver Metastases.
Tani K; Shindoh J; Takamoto T; Shibahara J; Nishioka Y; Hashimoto T; Sakamoto Y; Hasegawa K; Makuuchi M; Kokudo N
J Gastrointest Surg; 2017 May; 21(5):813-821. PubMed ID: 28083837
[TBL] [Abstract][Full Text] [Related]
26. Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.
Vreuls CP; Van Den Broek MA; Winstanley A; Koek GH; Wisse E; Dejong CH; Olde Damink SW; Bosman FT; Driessen A
Histopathology; 2012 Aug; 61(2):314-8. PubMed ID: 22571348
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases.
van den Broek MA; Vreuls CP; Winstanley A; Jansen RL; van Bijnen AA; Dello SA; Bemelmans MH; Dejong CH; Driessen A; Olde Damink SW
Ann Surg Oncol; 2013 May; 20(5):1462-9. PubMed ID: 23463086
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy.
Ryan P; Nanji S; Pollett A; Moore M; Moulton CA; Gallinger S; Guindi M
Am J Surg Pathol; 2010 Jun; 34(6):784-91. PubMed ID: 20421779
[TBL] [Abstract][Full Text] [Related]
29. [Chemotherapy's hepatotoxicity: what is the impact on surgery?].
Pessaux P
J Chir (Paris); 2010 Jan; 147 Suppl 1():S7-S11. PubMed ID: 20172202
[TBL] [Abstract][Full Text] [Related]
30. Hepatic Parenchymal Heterogeneity as a Marker for Oxaliplatin-Induced Sinusoidal Obstruction Syndrome: Correlation With Treatment Response of Colorectal Cancer Liver Metastases.
Han NY; Park BJ; Yang KS; Kim MJ; Sung DJ; Sim KC; Cho SB
AJR Am J Roentgenol; 2017 Nov; 209(5):1039-1045. PubMed ID: 28813196
[TBL] [Abstract][Full Text] [Related]
31. A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.
Narita M; Hatano E; Ikai I; Miyagawa-Hayashino A; Yanagida A; Nagata H; Asechi H; Taura K; Uemoto S
Ann Surg; 2009 May; 249(5):806-13. PubMed ID: 19387321
[TBL] [Abstract][Full Text] [Related]
32. Histological liver injury and surgical outcome after FOLFOX followed by a hepatectomy for colorectal liver metastases in Japanese patients.
Komori H; Beppu T; Baba Y; Horino K; Imsung C; Masuda T; Hayashi H; Okabe H; Ootao R; Watanabe M; Takamori H; Iyama K; Baba H
Int J Clin Oncol; 2010 Jun; 15(3):263-70. PubMed ID: 20238233
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation.
Cayet S; Pasco J; Dujardin F; Besson M; Orain I; De Muret A; Miquelestorena-Standley E; Thiery J; Genet T; Le Bayon AG
Eur J Radiol; 2017 Sep; 94():180-190. PubMed ID: 28712693
[TBL] [Abstract][Full Text] [Related]
34. LiMAx Test Improves Diagnosis of Chemotherapy-Associated Liver Injury Before Resection of Colorectal Liver Metastases.
Lock JF; Westphal T; Rubin T; Malinowski M; Schulz A; Jara M; Bednarsch J; Stockmann M
Ann Surg Oncol; 2017 Sep; 24(9):2447-2455. PubMed ID: 28516292
[TBL] [Abstract][Full Text] [Related]
35. Preoperative chemotherapy and the risk of hepatotoxicity and morbidity after liver resection for metastatic colorectal cancer: a single institution experience.
Wolf PS; Park JO; Bao F; Allen PJ; DeMatteo RP; Fong Y; Jarnagin WR; Kingham TP; Gönen M; Kemeny N; Shia J; D'Angelica MI
J Am Coll Surg; 2013 Jan; 216(1):41-9. PubMed ID: 23041049
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of chemotherapy-associated liver injury in patients with colorectal cancer liver metastases using indocyanine green clearance testing.
Krieger PM; Tamandl D; Herberger B; Faybik P; Fleischmann E; Maresch J; Gruenberger T
Ann Surg Oncol; 2011 Jun; 18(6):1644-50. PubMed ID: 21207168
[TBL] [Abstract][Full Text] [Related]
37. Hepatic Parenchymal Heterogeneity on Contrast-enhanced CT Scans Following Oxaliplatin-based Chemotherapy: Natural History and Association with Clinical Evidence of Sinusoidal Obstruction Syndrome.
Han NY; Park BJ; Kim MJ; Sung DJ; Cho SB
Radiology; 2015 Sep; 276(3):766-74. PubMed ID: 25822471
[TBL] [Abstract][Full Text] [Related]
38. Serum Type IV Collagen Concentration Correlates with Indocyanine Green Retention Rate.
Hosokawa Y; Watanabe M; Makino H; Mushiake H; Katsumata K; Maruno K; Fujino S; Sugiyama Y
Hepatogastroenterology; 2015 Jun; 62(140):825-8. PubMed ID: 26902010
[TBL] [Abstract][Full Text] [Related]
39. Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month.
Schouten van der Velden AP; Punt CJ; Van Krieken JH; Derleyn VA; Ruers TJ
Eur J Surg Oncol; 2008 Mar; 34(3):353-5. PubMed ID: 17207961
[TBL] [Abstract][Full Text] [Related]
40. Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases.
Volk AM; Fritzmann J; Reissfelder C; Weber GF; Weitz J; Rahbari NN
BMC Cancer; 2016 Feb; 16():84. PubMed ID: 26864935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
